Hypertension: all 6,834 studies

Page 45 of 69. Open to participants first (972), then studies with results posted, then the rest; newest registration first within each.

• Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial StiffnessStatus unknownNCT02617238Not applicable
• Effects of Standing and Light-intensity Activity on Ambulatory Blood Pressure and Blood GlucoseCompletedNCT02616809Phase 3
• Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart RateCompletedNCT02612298Phase 4
• Tracking Outcomes and Practice in Pediatric Pulmonary HypertensionCompletedNCT02610660
• Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedNCT02609490Phase 3
• Sympathetic and Blood Pressure Responses to Aerobic Exercise and Guided Respiration in HypertensivesCompletedNCT02608827Not applicable
• HFS-guided Renal Ablation for Improving Outcome of Renal Denervation ProcedureStatus unknownNCT02608632Phase 2
• Hypertension and Osteopathic TreatmentWithdrawnNCT02605551Not applicable
• Egypt Hypertension StudyCompletedNCT02604771
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisWithdrawnNCT02603068Phase 2
• A 2 Week, Crossover Trial of Dietary Nitrate in HTNCompletedNCT02597010Not applicable
• Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral HemodynamicsTerminatedNCT02596165Not applicable
• Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary HypertensionCompletedNCT02595541Phase 1/2
• Genetic and Environmental Determinants That Control Metabolism in Pulmonary HypertensionCompletedNCT02594917
• Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot StudyCompletedNCT02591628Not applicable
• Trial to Evaluate the Efficacy and Safety of HCP1302CompletedNCT02587988Phase 3
• Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus StimulationCompletedNCT02587533Not applicable
• CKD-330 Phase 3 Trial in Amlodipine Non-responderCompletedNCT02586311Phase 3
• Effects of Cured Pork Peptides on Blood Pressure & Cardiovascular Risk FactorsStatus unknownNCT02585089Not applicable
• A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With HypertensionCompletedNCT02585076
• Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP TreatmentTerminatedNCT02583906Not applicable
• Pulmonary Hypertension in Patients With Myeloproliferative NeoplasmsCompletedNCT02580903
• Cardiac Function and Exercise Capacity in Pulmonary Arterial HypertensionCompletedNCT02579954Not applicable
• Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese CanadiansCompletedNCT02579746Not applicable
• Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary StudyCompletedNCT02579655Not applicable
• Green Tea Attenuates Pressure Reduction Induced by a Session of Physical ExerciseCompletedNCT02578927Not applicable
• Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)CompletedNCT02576002
• Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated HypertensionCompletedNCT02575690Not applicable
• The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and TreatmentCompletedNCT02575092Phase 2/3
• Evaluation of Splenic Metabolic Activity With 18FDG-PET in HypertensionStatus unknownNCT02572765
• The Effect of BATon BP and Sympathetic Function in Resistant Hypertension (The Nordic BAT Study)CompletedNCT02572024Not applicable
• Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02571712Phase 4
• A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination TabletCompletedNCT02566187Phase 1
• Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle GlaucomaCompletedNCT02565173Phase 3
• Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term OutcomeCompletedNCT02565030
• The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive PatientsStatus unknownNCT02563405Phase 2/3
• Association of Dipping Pattern or Early Morning Surge of BP With Asymptomatic Episodes of Paroxysmal Atrial Fibrillation in Subjects With Hypertension (DIMOSPAF)Status unknownNCT02563379
• How to Test Success of a Renal DenervationTerminatedNCT02559882
• Effect of Exercise Training in Patients With Pulmonary HypertensionStatus unknownNCT02558582Not applicable
• The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus NicardipineTerminatedNCT02558023Phase 3
• Early Non-invasive Detection of CTEPH After Pulmonary EmbolismCompletedNCT02555137
• Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt LesionsCompletedNCT02552485
• iPhone App Compared to Standard RR-measurementCompletedNCT02552030Not applicable
• Health Education Using Text Messaging Prevents Hypertension in High Risk PeopleStatus unknownNCT02551926Not applicable
• Enhancing the Risk Assessment and Management Program by Promotion of Self-blood Pressure MonitoringCompletedNCT02551393Not applicable
• Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsCompletedNCT02548286Phase 1
• Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Edema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary HypertensionStatus unknownNCT02548091Not applicable
• Heat & Aerobic Training (HEAT) StudyCompletedNCT02546726Not applicable
• A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical PracticeCompletedNCT02545465
• Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)TerminatedNCT02539810Phase 4
• Electronic Activity Level Monitoring Pilot in Pulmonary HypertensionCompletedNCT02536534
• LEPU Renal Denervation System for Resistant HypertensionCompletedNCT02536326Phase 3
• Anti-hypertensive Effect of Mycelia of Antrodia CinnamomeaCompletedNCT02532699Not applicable
• Early Vascular Adjustments During Hypertensive PregnancyStatus unknownNCT02531490Phase 4
• Comparison of Telemedical and Conventional Treatment of HypertensionCompletedNCT02531347Not applicable
• 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT02531152Phase 1
• Acupuncture as a Complementary Treatment for Hypertension (ACT-HAS)Status unknownNCT02530853Not applicable
• The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy SubjectsStatus unknownNCT02527837Phase 1
• Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately ControlledStatus unknownNCT02526875Phase 4
• Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis CCompletedNCT02526641
• Pulmonary Artery Denervation for Treatment of Pulmonary Arterial HypertensionTerminatedNCT02525926Not applicable
• Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in HypertensionCompletedNCT02524873
• Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive PregnancyCompletedNCT02523781Not applicable
• Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension ControlWithdrawnNCT02521246Phase 3
• Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02521233Phase 3
• Effects of Dietary Nitrate in Hypertensive Pregnant WomenCompletedNCT02520687Not applicable
• Chemical Block and Electrical Stimulation of the Carotid Body to Treat Refractory HypertensionWithdrawnNCT02519868Not applicable
• Microcirculation After MAP Increase in Septic Shock Patients With Previous HypertensionCompletedNCT02519699Phase 4
• Oral Nitrite Trial for Hypertension and Metabolic SyndromeWithdrawnNCT02517697Phase 2
• TReatment Of Pulmonary HYpertension 1 StudyStatus unknownNCT02516722Not applicable
• Equol Supplementation on Blood Pressure and Vascular FunctionStatus unknownNCT02515682Not applicable
• Intra-abdominal Hypertension in Critically Ill PatientsCompletedNCT02514135
• Postoperative Pain and Angiotensin II Receptor AntagonistsStatus unknownNCT02513979Phase 4
• The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern ChineseStatus unknownNCT02513927Phase 2/3
• Prevalence of Resistant Hypertension With DOTCompletedNCT02513524
• Burdock and Blood Pressure in African-American WomenStatus unknownNCT02511860Not applicable
• A Team-Based Care for Hypertension Management (TBC-HTA)Status unknownNCT02511093Not applicable
• Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal VaricesStatus unknownNCT02508623Phase 3
• Surrogate Markers of Portal PressureCompletedNCT02508298Not applicable
• Hypertension With Unsatisfactory Sleep HealthCompletedNCT02508129Not applicable
• Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After SplenectomyStatus unknownNCT02505152Not applicable
• Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male SubjectCompletedNCT02504606Phase 1
• Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal VeinStatus unknownNCT02504034Not applicable
• Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese DiabetesStatus unknownNCT02503943Phase 4
• REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS TrialCompletedNCT02499822Phase 4
• PK Study of YH22162 FDC Compared to Combination of Twynsta and HygrotonCompletedNCT02496910Phase 1
• Renal Nerves Stimulation StudyCompletedNCT02496117Phase 2
• Fimasartan Achieving SBP Target (FAST) StudyCompletedNCT02495324Phase 4
• Lifestyle Intervention for Treating Systemic Hypertension in Primary Care SettingCompletedNCT02492035Not applicable
• Cardiac MRI in Pulmonary HypertensionCompletedNCT02485977
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnNCT02483936Phase 3
• We Talk About Our HypertensionCompletedNCT02483780Not applicable
• Iloprost for Bridging to Heart Transplantation in PHWithdrawnNCT02482402Phase 2
• Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular RiskCompletedNCT02482207Phase 4
• The Dutch National Renal Denervation RegistryStatus unknownNCT02482103
• Sham Controlled Study of Renal Denervation for Untreated Stage I and II HypertensionStatus unknownNCT02480517Not applicable
• Assessing Blood Pressure Remotely in Childhood Cancer SurvivorsCompletedNCT02476162
• Epidemiological Study in Thai Participants With HypertensionCompletedNCT02467855
• Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential HypertensionCompletedNCT02466490Phase 3
• To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.CompletedNCT02465645Not applicable

← Hypertension overview